Condition
Peritoneal Neoplasms|Retroperitoneal Neoplasms|Gastrointestinal Neoplasms|Adenocarcinoma|Neuroblastoma|Ovarian Neoplasms|Sarcoma|Adrenocortical Carcinoma|Wilms Tumor|Rhabdomyosarcoma|Desmoplastic Small Round Cell Tumor
Estimated Enrollment: 10
Age Group: 3 Years to 18 Years (Child, Adult)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 2005-0917
Study First Received: February 15, 2007
Last Updated: March 29, 2012
Estimated Primary Completion Date: April 2011
Primary Outcome Measures:
Maximum Tolerated Dose (MTD) of continuous hyperthermic peritoneal perfusion (CHPP) with cisplatin in children with peritoneal cancer
Sponsors and Collaborators:
M.D. Anderson Cancer Center
Website Link: https://ClinicalTrials.gov/show/NCT00436657
